Xeomin

Xeomin

XEOMIN is an advanced botulinum toxin treatment designed to address a variety of medical and therapeutic concerns while helping improve overall comfort and day-to-day functioning in both adults and children. It is widely used in clinical practice due to its precision-focused formulation and consistent performance across different treatment areas.

This treatment is particularly useful for managing conditions such as excessive drooling, muscle tightness, cervical dystonia, and involuntary eyelid spasms. XEOMIN works by targeting the specific muscles or glands responsible for these symptoms, helping to reduce overactivity and restore more natural movement or function. Its formulation contains only the active component, incobotulinumtoxinA, without additional complexing proteins, which contributes to a lower likelihood of sensitivity or immune-related responses.

Key Benefits:

• Chronic Drooling (Sialorrhea)
  XEOMIN helps control excessive saliva production in both adults and children aged 2 to 17. By acting on the salivary glands, it reduces drooling and improves comfort in social and daily situations.

• Muscle Stiffness (Upper Limb Spasticity)
  For adults, it supports relief from stiffness in the arms caused by upper limb spasticity, allowing improved flexibility and ease of movement. In children within the same age group, it is used for stiffness not associated with cerebral palsy, helping enhance mobility and function.

• Cervical Dystonia
  XEOMIN assists in reducing abnormal head positioning and discomfort in the neck area. Patients often experience better posture control and reduced muscle tension after treatment.

• Blepharospasm (Eyelid Spasms)
  It helps manage uncontrolled eyelid movements by calming the affected muscles, leading to improved eye comfort and better visual function.

• High Purity Formulation
  Since XEOMIN contains only the essential active ingredient, it offers a more refined approach with reduced chances of allergic reactions compared to formulations that include additional proteins.

• Ease of Handling
  The formulation is stable and convenient for medical professionals, as it does not require refrigeration before being prepared for use, simplifying storage and transport conditions.

• Lower Risk of Treatment Resistance
  The absence of accessory proteins reduces the possibility of the body developing resistance over time, making it suitable for repeated treatments when needed.

• Noticeable Results with Sustained Effect
  Patients may begin to observe changes relatively quickly, with results typically lasting between three to six months depending on individual response and treatment type.

Storage Instructions:

• Before Reconstitution:
  Store XEOMIN in a refrigerator at a temperature between 2°C and 8°C (36°F to 46°F).

• After Reconstitution:
  Once prepared, it should be kept in its original container and used within 24 hours for optimal effectiveness.

• Single-Use Policy:
  Each vial is intended for one-time use only. Any remaining product should be discarded after the treatment session.

Guidelines for Use:

• Reconstitution:
  Each vial must be carefully mixed with sterile, preservative-free 0.9% Sodium Chloride Injection before administration, following recommended procedures.

• Injection Areas:
  XEOMIN is administered either into muscles or directly into salivary glands, depending on the condition being treated. The number and location of injections are determined by the treatment plan.

• Treatment Interval:
  Subsequent sessions are generally scheduled no earlier than 12 to 16 weeks after the previous treatment, based on patient response and medical advice.

Caution:
Proper anatomical knowledge is essential when administering XEOMIN. Healthcare professionals should exercise care when treating areas near sensitive structures to ensure safe and precise delivery.

Indications:

• Management of chronic sialorrhea in adults and children aged 2 to 17.

• Treatment of upper limb spasticity in both adults and children (excluding cases related to cerebral palsy).

• Relief from cervical dystonia symptoms in adults.

• Control of blepharospasm in adult patients.

Composition:

• IncobotulinumtoxinA as the primary active component

• Lidocaine 0.3% included for added comfort during administration

XEOMIN offers a targeted and reliable approach for managing both functional and neurological conditions. Its clean formulation, combined with predictable outcomes, makes it a preferred choice among healthcare professionals. Patients benefit from improved symptom control, enhanced comfort, and a treatment option that fits well into long-term care plans.

Additional Information:
When used appropriately, XEOMIN allows for precise customization based on individual patient needs. Its flexibility across different therapeutic areas makes it suitable for a wide range of cases. Many patients appreciate the balance it provides between effectiveness and subtlety, helping them maintain natural movement while addressing specific concerns. Regular follow-ups and professional guidance ensure that results remain consistent and aligned with treatment goals over time.